Condition: Human Immunodeficiency Virus · Smoking Cessation · Smoking, Tobacco · Sponsor: University of Colorado, Denver
The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)
This description comes directly from the study's public registry record.
Gina Kruse, MD · 303-724-4811 · gina.kruse@cuanschutz.edu
Yamila L Sierra, MPH · (303) 724-4549 · yamila.sierra@cuanschutz.edu
Always discuss trial participation with your own doctor first.
| University of Colorado | Aurora, Colorado, United States | Recruiting |
| VHS Infectious Disease Medical Centre, CART Clinical Research Site | Chennai, Tamil Nadu, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05786547